Given the complexity of the immune system network and the multidimensionality of host‐tumor interactions, NF‐κB and GDF‐15 may be signature molecules that can elucidate the molecular kinetics of inflammatory responses early in prostatic carcinogenesis. The gene discussed is NFKB1; the disease is neoplasm.